prior to now number of years, the united kingdom has witnessed a revolution in clinical excess weight‑decline solutions — in the introduction of semaglutide (Wegovy®) on the expanding attractiveness of tirzepatide (Mounjaro®). Now, A further identify is drawing consideration in the two medical an